PHUONG TANG: Open Payments
NPI 1609128693 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 9 payments from 5 companies in 2025. Trend: 2023 $862 · 2024 $1,049 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
| PFIZER INC. | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Madrigal Pharmaceuticals | 1 | $28 |
| ABBVIE INC. | 1 | $14 |
Products named: XIFAXAN, XELJANZ, IQIRVO, REZDIFFRA, RINVOQ.
Industry payments across CA — which companies pay providers there.
